M&A Deal Summary |
|
|---|---|
| Date | 2025-09-30 |
| Target | Clearwater |
| Sector | Information Technology |
| Buyer(s) | Sunstone Partners |
| Sellers(s) | Altaris |
| Deal Type | Secondary Buyout |
| Advisor(s) | Stephens (Financial) ArentFox Schiff (Legal) |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 2015 |
| PE ASSETS | 1.7B USD |
| Size | Large |
| Type | Sector Focused |
Sunstone Partners is a private investment firm focused on growth equity investments in and majority buyouts of tech companies. The Firm targets opportunities throughout North American and seeks businesses with at least $20 million in revenues and at least 20% of yearly growth. Sunstone Partners was formed in 2015 from a team that previously worked together at Trident Capital. The Firm is based in San Mateo, California.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 17 |
| Sector: Information Technology M&A | 8 of 8 |
| Type: Secondary Buyout M&A Deals | 1 of 1 |
| State: Tennessee M&A | 1 of 1 |
| Country: United States M&A | 16 of 16 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-11-22 |
KMS Technology
Atlanta, Georgia, United States KMS Technology is a provider of digital engineering, data, AI, and consulting services. KMS Technology was founded in 2009 and is based in Atlanta, Georgia. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 10.0B USD |
| Size | Mega |
| Type | Sector Focused |
Altaris is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris was formed in 2004 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 28 of 28 |
| Sector: Information Technology M&A | 3 of 3 |
| Type: Secondary Buyout M&A Deals | 9 of 9 |
| State: Tennessee M&A | 3 of 3 |
| Country: United States M&A | 26 of 26 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-25 |
WuXi AppTec - Advanced Therapies
Shanghai, China WuXi AppTec's Advanced Therapies offers customers a complete cell therapy outsourcing solution, including viral vector manufacturing, cell therapy process development and manufacturing, and biosafety testing. |
Buy | - |
